DexCare Raises $50M in Series B Funding
Summary
The company intends to use the funds to accelerate growth with investments in product and technology innovation, customer experience, and recruiting talent. Led by Derek Streat, CEO, DexCare provides a Platform-as-a-Service (PaaS) for health systems that intelligently orchestrates digital demand and health system capacity across all lines of care. The data-driven intelligence engine allocates, flexes and optimizes resources to meet both consumer demand and health system business goals—expanding the reach of health system service lines into a new, digital and on-demand consumer arena. The platform attracts and caters to high-value consumers by providing a fully-digitized, unified experience that routes consumers to the best care options while leveraging existing EMR, caregiver and brand investments. In 2021, the company expanded its platform to power access across a variety of applications including: Incubated at Providence, DexCare has closed two funding rounds totaling $71M to-date.
Funding
Review available funding amount, funding date, investors, and linked company information related to DexCare Raises $50M in Series B Funding in the interactive ISVWorld profile.